Science to Public Health:
in the Population”
Washington, D.C., Hyatt Regency
May 25–27, 2005
Pre-conference Workshops May 24, 2005
Program Committee of the Society for Prevention Research (SPR) invites submissions
for presentations within all content areas of public health, education, human
services, criminal justice, and medical science to submit proposals. Relevant
topics include, but are not limited to, health promotion, maternal health, infant
and child health, mental health/mental disorders, family conflict, substance abuse
and addiction (alcohol, tobacco, illicit drugs), violence, delinquency, crime,
academic failure, dropping-out of school, cardiovascular disease, cancer, HIV/AIDS
and other sexually transmitted disease, unintended pregnancy, unemployment, occupation
safety, auto accidents, unintended injury, poverty, welfare, and managed care.
Prevention researchers across international regions, including
developed and developing countries, are encouraged to submit. Submissions for
presentations may include individual paper and poster presentations, organized
paper symposia, organized poster symposia, round-table discussions/scientific
dialogue sessions, or technology demonstrations.
Dates and Venue
The meeting will take place from May 25 to May 27, 2005 at the
Hyatt Regency Washington. The hotel is located on Capitol Hill at 400 New Jersey
Avenue, NW, in the heart of Washington, D.C. and within a short walk to all major
attractions, shopping and commerce areas, including the U.S. Capitol, National
Mall, Smithsonian Museums, Union Station, and Congressional offices.
The conference theme, “Prevention Science to Public Health,
Promoting Well-Being in the Population,” is meant to be comprehensive.
Special Topic Themes for 2005
Economic & Cost-Utility Analysis
Studies that include short and long-term costs and economic benefits of prevention
interventions are rare, yet extremely important to policymakers. Thus, SPR encourages
research submissions that include economic analyses and discussions of implications
for public policy.
Integrating Biological & Social Factors in Prevention
The last decade has seen major breakthroughs in understanding the biological bases
of behaviour, especially in behavioural genetics, imaging, and neuroscience. Increasingly,
biobehavioral research paradigms must be employed to understand the expression
of basic biological processes in everyday life. Prevention researchers must be
at the forefront of leading the initiatives for this research.
Health promotion is not driven by an emphasis on illness, but rather by a focus
on the enhancement of well-being. It is provided to individuals, groups, or large
populations to enhance competence and self-esteem rather than to intervene to
prevent psychological or social problems or mental disorders.
Middle Childhood Development
Research on effective factors and programs for promoting healthy childhood development
and well-being and preventing serious social, emotional, physical and cognitive
programs in school age children in elementary and middle grades.
Emerging Opportunities for Prevention Research
In addition to emphasizing the conference theme, SPR continues its interest and
commitment to the following topic areas of emerging importance that are shaping
children and families daily routines, risk factors for behavioural problems, and
• Monitoring Systems for Youth and Children
• Faith-Based Interventions
• The Internet
Cross-Cutting Thematic Papers
Using the best available scientific methods, researchers must evaluate the efficacy
and effectiveness of preventive methods, thus providing more information for community
practitioners. Both treatment and prevention research continue to try to recruit
competent scientists to their respective fields in the face of inadequately funded
Cultural sensitivity is the awareness of a body of important information relevant
to the populations of interest, which should inform the entire research process,
from defining the sampling frame, through negotiating access, to actual intervention
and dissemination of results. Cultural differences and similarities exist and
have an effect on values, learning, and behavior. Research must be sensitive to
the health beliefs and behaviors, epidemiology, and treatment efficacy of different
population groups. Recognizing health care disparities, functioning within a multicultural
framework, and meeting the demands of an increasingly diverse society are priorities
for all research .
Knowing the prevalence of specific problems or disorders, the distribution of
risk factors in the population, and shifts in risk factors and the distribution
of problems over time is key to designing any effective prevention program. An
emphasis on basic behavioural science and epidemiology will remain the basis of
strong intervention and prevention programs. Epidemiological studies typically
reflect phase 1 and 2 trials in a biomedical model of intervention development.
Prevention science includes research that has a high probability of yielding results
that will likely be applicable to disease prevention. Basic research efforts generate
knowledge that contributes to the development of future preventive efforts. Etiological
studies typically reflect Phase 1 trials in a biomedical model.
Efficacy trials demonstrate the “proof of concept” with a specified
population under conditions of high quality assurance and strong research designs
(typically randomized controlled designs). Efficacy trials answer the basic question
of whether there are benefits from a proposed innovation. In a biomedical model
of intervention development, these are Phase 3 trials.
The true test of a prevention program is not the efficacy in the research setting
but the effectiveness in the real-life setting with the community in charge of
the program. Effectiveness trials involve replicating an efficacious intervention
under real world conditions in community settings. There is less quality assurance
on an ongoing basis and the outcomes demonstrate the likely impact of an intervention
when delivered without the original research team. In a biomedical model, these
are Phase 4 trials.
Careful trials to assess which programs would be particularly well suited for
dissemination, which individuals would be most likely to benefit, and which disorders
are prevented are important steps in program development Almost no interventions
have been taken to scale nationally or internationally; dissemination research
identifies strategies for taking interventions to scale and identifies potential
barriers to dissemination.
Information for Authors
The Community of Science (COS) Web site will be managing our
abstract submissions this year. The COS site is available for submissions beginning
Wednesday, September 1, 2004 .
HERE to submit your abstract. To facilitate reviews and scheduling, all abstracts
will be submitted via the Web site. Special arrangements may be worked out through
the SPR administrative office for those unable to access the Internet.
In order to review all submitted work, we ask that all abstracts be submitted
no later than 11:59 pm, Eastern Time, Wednesday, October 6, 2004.
Sumbission deadline extended to October 13,2004!
note that abstract text cannot exceed approximately 400 words, or 2800 characters
Abstracts to SPR
should focus on the theme of the SPR Annual Meeting and the mission of SPR and
may consist of reports of empirical findings, discussions of theoretical, conceptual
or methodological issues, and presentations of innovative work in the field of
prevention science. Research conducted at all phases of the prevention research
cycle are welcomed, including studies of epidemiology, etiology, preventive intervention
trials, demonstration projects, policy research, natural experiments, program
evaluations, clinical trials, prevention-related basic research, pre-intervention
studies, efficacy and effectiveness trials, population trials, and studies of
the diffusion/dissemination of science-based prevention.
and advocates within all content areas of public health, education, human services,
criminal justice, and medical science that focus on preventive behavioral interventions,
prophylactics, or health policy strategies are welcome to submit on relevant topics,
including, but not limited to health promotion, maternal health, infant and child
health, mental health/mental disorders, family conflict, substance abuse and addiction
(alcohol, tobacco, illicit drugs), violence, delinquency, crime, academic failure,
dropping-out of school, cardiovascular disease, cancer, HIV/AIDS and other sexually
transmitted disease, unintended pregnancy, unemployment, occupation safety, auto
accidents, unintended injury, poverty, welfare, and managed care.
Further, SPR strongly
encourages submissions by early career prevention scientists, including graduate
students, post-doctoral fellows, and researchers who have recently begun to work
One of SPR’s
missions is to facilitate the development of more junior prevention scientists.
We encourage senior researchers to collaborate with early career researchers and
submit linked abstracts for presentations on specific themes or individual projects.
These need not be limited to organized paper or poster symposia presentations.
Given the limited
time and rooms for oral presentations, we are especially interested in organized
paper and poster symposia that include authors from a variety of research groups
and from more than one project. The Program Committee also encourages organized
paper and poster symposia consisting of several authors from single research studies,
such as multi-site and/or longitudinal studies.
We are continuing
to accept submissions for organized poster sysmposia which was a new format introduced
at the 2004 annual meeting. The organized poster symposium combines the individual
interactions of a poster presentation and the extended group discussion opportunities
of an organized symposium.
We encourage authors
to consider submitting an individual poster presentation. We seek broad participation
in the conference, and many individual poster presentations can be accommodated.
We will again combine the two evening poster sessions with receptions to enhance
Please note that
all submissions must be in English as all presentations will be in English.
Abstracts of individual research papers may be submitted for a 15-minute oral
presentation. A maximum of three individual papers will be grouped together based
on a theme within a 90-minute concurrent session. A volunteer chair will facilitate
an extended period of open discussion following the three oral paper presentations.
Poster displays allow presenters to discuss their research with interested colleagues
during a two-hour block of time. The poster sessions will be held in the early
evening along with a reception, and will not compete with any other sessions.
An organized paper symposium provides for multiple oral research presentations
to be made on a single theme involving a brief introduction by the chair, 3 (maximum)
presenters, with one discussant (encouraged, though optional) and open discussion
from the floor. Presenters have 15 minutes to present the core content and the
discussant has 15 minutes to comment upon the presentations with 30 minutes reserved
for interactive discussion, facilitated by the chair, between the presenters and
the session audience. An abstract should be submitted that describes the overall
symposium, and separate abstracts should be submitted for each proposed presentation
(that is, 4 abstracts should be submitted for a symposium with 3 presenters).
An organized poster symposium provides for multiple, 4-8 (maximum), poster research
presentations to be made on a single theme. Posters will be displayed for a 45-minute
period allowing time for presenters to individually discuss their research with
the session audience as they move through the posters. 15 minutes is allocated
for comments from a discussant (encouraged, though optional) and 30 to 45 minutes
(if no discussant) of general discussion, moderated by the chair, between the
presenters and the session audience.
A roundtable discussion/scientific dialogue (RD/SD) does not present research
findings, but rather addresses an area or issue of fundamental importance to the
field, in a format that encourages a lively exchange of different points of views.
Examples include training and funding opportunities in prevention, priorities
in prevention, and advocacy for the use of scientific approaches to prevention.
The RD/SD chair and the panel of 3-6 discussants often include members/people
outside the research community. The 90-minute RD/SD should include a brief introduction
clearly outlining the issues presented by the chair followed by each of the discussants
elaborating on their different viewpoints and perspectives on the issue. Then
the chair facilitates extended open discussion with the session audience and the
discussants. The RD/SD abstract submission should include only one abstract (unlike
an organized symposium), which should include the names of the chair and the discussants,
an outline of the issue and varying viewpoints and indicate which discussant will
be elaborating on each viewpoint.
Abstracts are encouraged that describe prevention-related technology and science-based
prevention program materials. A technology demonstration session will be presented
during the conference for "hands-on" presentations of technology, such
as statistical analysis programs, data collection instruments and techniques,
literature search techniques, or science-based prevention curricula. The technology
demonstration session will be held in the early evening along with a reception
concurrently with the poster sessions.
All persons associated
with an abstract submission shall be included in the abstract author information.
Please select author roles carefully. To maximize participation in oral presentations
a limit on a Presenting Author’s abstract submissions has been instituted.
Oral presentations are limited to TWO per person, therefore when inviting your
presenters for an organized symposium, confirm that they have not already committed
to more than one other organized symposium presentation or an individual oral
presentation. Chairing a symposium or being a discussant does not count as an
By – This individual is responsible for accurate entering of all
abstract information and may or may not be an author or presenter. There is a
minimum and maximum of one “Entered By.”
Author – This individual is the primary author of the abstract
and/or research paper. The primary author may or may not be a presenting author
and may or may not attend the meeting. There is a minimum and maximum of one “Primary
Author – This individual is the presenter for oral (both individual
papers or within an organized symposium) and poster presentations and technology
demonstrations. This individual must attend the meeting. There is a minimum and
maximum of one “Presenting Author.” A presenting author is limited
to TWO oral presentations in the meeting.
– This individual(s) is a co-author on the abstract and/or research paper.
Co-authors may or may not attend the meeting. There is no minimum or maximum requirement
– This individual organizes the symposium, roundtable/scientific discussion
or poster symposium. The chair is responsible for coordinating the presenters’
abstracts, selecting the theme for the submission and that the presenters and
discussant attend the meeting. The Chair acts as moderator to ensure presenters
keep to the 15-minute time limit and to facilitate the open discussion segment
of the session. The Chair must attend the meeting. There is a minimum and maximum
of one Chair for an organized symposium, roundtable/scientific dialogue and poster
– This is an optional role in organized symposia and a role in roundtable
discussions/scientific dialogues. Discussants are not expected to give presentations.
In an organized symposium a discussant’s role/goal is to identify common
themes among the presentations, clarify the “big-picture,” and integrate
the research presentations. In a roundtable/scientific discussion a discussant’s
role is to elaborate on varying perspectives within the specified area or issue.
Discussants are not limited to the number of organized symposia or roundtable/scientific
dialogues in which they participate.
all Presenting Authors, Chairs and Discussants – If your
abstract(s) and session(s) are accepted you are required to register for the meeting.
ABSTRACT SUBMISSION RULES
The direct URL
for the Society for Prevention (SPR) COS abstract submission site is http://ams.cos.com/cgi-bin/login?institutionId=32607&meetingId=187
or you can click
here to go to the COS Log in Page. Note: you must activate cookies to use
the COS site. When you are on the COS site each abstract submission step has its
own set of instructions displayed.
It is important to note that throughout the abstract submission process you MUST
press the "Acknowledge and Continue" button at the bottom of the page.
BY STEP ABSTRACT SUBMISSION GUIDE
The direct URL
here to link to the COS Log In Page
Enter your COS username and password.
New to the COS System? Click on the link “Create a New Account”
o Another screen will appear, asking you for some information.
o COS will then email you your username and password.
After you log in, you will be taken to the Electronic Submission page.
Click Create/Edit an Abstract to begin the submission process or to edit
an abstract that you’ve already started.
The next page, Status of Current Documents page, lists all the abstracts
associated with your name. This page will be blank (you will not see any abstracts
associated with your name) when you log in for the first time unless someone else
has entered an abstract with you as one of the authors.
You can “Create a New Abstract” or “Edit” an existing
The status (draft, submitted, accepted, rejected) of all your abstracts
(if you have already started some) is listed in the table as well.
Step 1: Identify the type of abstract you are submitting. You
must select one type of submission, and you cannot change the submission from
one type to another once you have made that choice. i.e., you cannot change a
submission from a poster to a paper once you have begun.
From here you
are taken to the actual submission process. The submission steps are listed on
the left-hand side of the screen, and they will automatically be checked off as
you complete each step of the submission process. You can go to any step by clicking
Identify authors for each submission.
The screen will allow you to see up to three authors at one time, although you
may have to scroll down the screen to see all the information on each author.
You should identify which person listed may edit the submission, and you should
identify each person as one of the following:
- Entered By (the
person doing the actual submission)
- Primary Author
- Presenting Author
- Chair (organized
paper and poster symposia and roundtable discussion/scientific dialogue)
- Discussant (organized
paper and poster symposia and roundtable discussion/scientific dialogueEach
added person must be identified as one of these author types.
To identify additional
authors, you may select to:
- Find New Author
to Add from the SPR/COS Database (information will be entered for you). USE THIS
SELECTION TO AVOID ENTERING DUPLICATE RECORDS WITH A MINOR NAME VARIANT FOR AN
AUTHOR ALREADY IN THE DATABASE.
- Add New Author
Without Searching (you need to enter author information)
- Add New Author
Without Searching using Address Information from an already identified Author
– this option will allow you to automatically fill the affiliation information
using one of the already entered author information.
- Note that additional
authors will appear in new columns that appear towards the bottom of the page.
After you have clicked to add a new author, scroll down if you cannot see the
new author information.
When you are finished adding authors, click on “Save and Close.”
Title and Abstract Text: We strongly urge you to compose your abstract
submission electronically before you begin this process, so you may cut and paste
text into the appropriate fields. However, please be aware of the following:
- TEXT CANNOT EXCEED
APPROXIMATELY 400 WORDS, OR 2800 CHARACTERS INCLUDING SPACES.
- Special characters,
including mathematical operators such as FIND THESE=, = and ˜, will not be
transmitted over the Internet. After you have placed text in the appropriate fields,
use the “Special Character” key above the title field to insert special
characters. These will be inserted wherever your cursor was on the screen before
you selected your special character. You may cut and paste these to anywhere in
the text. Be sure to move the following semi-colon as well.
- You can view
your abstract in the format it will appear in the SPR annual meeting printed program
by clicking on the "View Program Format" button, right next to the Title
Abstract Theme: You must select an abstract theme. Only one
theme per abstract submission.
Step 5 Key Words: Select as many keywords as apply.
Step 6 AudioVisual Equipment Requests
Step 7 Conflict of Interest Disclosure Statement (required).
Please complete as appropriate for each author.
Step 8 Proofread: You must proofread your submission
Step 9 (optional): Co-author Editing: You may choose
to have co-author(s) edit the abstract, to the extent you identified who have
the right to do so. Provide co-authors with the tracking ID number to facilitate
Step 10 Submit: After proofreading, and editing if necessary,
please hit the submit button. Your submission will remain in “draft”
status until you, as the entering author, click the “Submit” button.
The deadline for submitting is Wednesday, October 6, 2004, at 11:59 PM ET.
Enter and Save Data
Open "Submit an Abstract" section on the left by pressing the section
title which will change it to bold red text.
- Enter data and
press the "Save" or "Save and Continue" button at the bottom
which will save the data for that section
- Open the next
- The abstract will
be marked "Draft" if you exit before completing the process
Press the "Submit"
button in the last section if a check mark exists in every section which will
change the status of the abstract from "Draft" to "Submitted for
• All abstracts on which you are an author will be listed and marked either
"Draft" or "Submitted for Review" if you login at a later
• All abstracts in "Draft" may be edited at any time through 11:59
PM (ET), October 6, 2004.
• After October 6, 2004, you may review your abstracts but not edit them
• After October 6, 2004, abstracts marked "Draft" will not be
considered for inclusion in the program
Please don’t hesitate to contact the administrative office
with submission questions. Jennifer Lewis will gladly walk you through any of
the submission steps. In particular you may benefit from a few minutes of explanation
as to how to start the organized symposia submission process.
Society for Prevention Research
7531 Leesburg Pike, Suite 300
Falls Church, VA 22043
Web site: www.preventionresearch.org